Note: Ancora Heart's revenues are gauged from an analysis of company filings.
Ancora Heart has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
December 28, 2018
Complete list of funding rounds and total amounts in the Company Report
Ancora Heart's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Ancora Heart Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Ancora Heart is developing and marketing.
Ancora Heart doesn't have any recent trademark applications, indicating Ancora Heart is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
BASAL VENTRICULOPLASTY Medical and surgical catheters; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus for preventing or reversing heart failure; Medical apparatus for treating congestive heart failure; Medical devices for treating congestive heart failure
SMARTCINCH Medical devices for use in cardiac remodeling and repair, namely, implants consisting of artificial matter, anchors, cables, and catheters; surgical apparatuses used to deliver cardiac implants for use in cardiac remodeling and repair; medical catheters used to deliver cardiac implants for use in cardiac remodeling and repair
Determine whether Ancora Heart grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Ancora Heart is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Ancora Heart vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Ancora Heart, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Ancora Heart.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Ancora Heart and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.